A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]

NCT07390383 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumour

Interventions

DRUG: LBL-024 for Injection
DRUG: Capecitabine tablets
DRUG: Tislelizumab Injection
DRUG: Oxaliplatin injection

Sponsor

Nanjing Leads Biolabs Co.,Ltd

Collaborators

[object Object]